146 related articles for article (PubMed ID: 38435107)
21. Clinical presentation and treatment outcome of retinoblastoma in children of South Western China.
Gao J; Zeng J; Guo B; He W; Chen J; Lu F; Chen D
Medicine (Baltimore); 2016 Oct; 95(42):e5204. PubMed ID: 27759657
[TBL] [Abstract][Full Text] [Related]
22. Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes.
Say EA; Iyer PG; Hasanreisoglu M; Lally SE; Jabbour P; Shields JA; Shields CL
J AAPOS; 2016 Aug; 20(4):337-42. PubMed ID: 27328850
[TBL] [Abstract][Full Text] [Related]
23. A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma: Part II: Treatment Success and Globe Salvage.
Tomar AS; Finger PT; Gallie B; Mallipatna A; Kivelä TT; Zhang C; Zhao J; Wilson MW; Brenna RC; Burges M; Kim J; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català J; Correa-Llano G; Carreras E;
Ophthalmology; 2020 Dec; 127(12):1733-1746. PubMed ID: 32526306
[TBL] [Abstract][Full Text] [Related]
24. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
[TBL] [Abstract][Full Text] [Related]
25. Forget-me-nots in the care of children with retinoblastoma.
Shields CL
Semin Ophthalmol; 2008; 23(5):324-34. PubMed ID: 19085435
[TBL] [Abstract][Full Text] [Related]
26. Retinoblastoma in Turkey: results from a tertiary care center in Ankara.
Gündüz K; Köse K; Kurt RA; Süren E; Taçyildiz N; Dinçaslan H; Ünal E; Erden E; Heper AO
J Pediatr Ophthalmol Strabismus; 2013; 50(5):296-303. PubMed ID: 23937863
[TBL] [Abstract][Full Text] [Related]
27. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
Ghassemi F; Shields CL; Ghadimi H; Khodabandeh A; Roohipoor R
JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
[TBL] [Abstract][Full Text] [Related]
28. [Late presentation of bilateral retinoblastoma: case report].
Melo MC; Ventura LM; Erwenne CM; Arcoverde AL
Arq Bras Oftalmol; 2008; 71(3):437-42. PubMed ID: 18641839
[TBL] [Abstract][Full Text] [Related]
29. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
Shields CL; Kaliki S; Shah SU; Bianciotto CG; Liu D; Jabbour P; Griffin GC; Shields JA
Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042
[TBL] [Abstract][Full Text] [Related]
30. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
Berry JL; Kogachi K; Aziz HA; McGovern K; Zolfaghari E; Murphree AL; Jubran R; Kim JW
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 28221729
[TBL] [Abstract][Full Text] [Related]
31. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
[TBL] [Abstract][Full Text] [Related]
32. A 20-year audit of retinoblastoma treatment outcomes.
Gündüz AK; Mirzayev I; Temel E; Ünal E; Taçyıldız N; Dinçaslan H; Köse SK; Özalp Ateş FS; Işık MU
Eye (Lond); 2020 Oct; 34(10):1916-1924. PubMed ID: 32376976
[TBL] [Abstract][Full Text] [Related]
33. Retinoblastoma in Asia: Clinical Presentation and Treatment Outcomes in 2112 Patients from 33 Countries.
Kaliki S; Vempuluru VS; Mohamed A; Al-Jadiry MF; Bowman R; Chawla B; Hamid SA; Ji X; Kapelushnik N; Kebudi R; Sthapit PR; Rojanaporn D; Sitorus RS; Yousef YA; Fabian ID;
Ophthalmology; 2024 Apr; 131(4):468-477. PubMed ID: 37839559
[TBL] [Abstract][Full Text] [Related]
34. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
Demirci H; Eagle RC; Shields CL; Shields JA
Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
[TBL] [Abstract][Full Text] [Related]
35. Clinical course of retinoblastoma.
Islam F; Zafar SN; Siddiqui SN; Khan A
J Coll Physicians Surg Pak; 2013 Aug; 23(8):566-9. PubMed ID: 23930873
[TBL] [Abstract][Full Text] [Related]
36. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
Shields CL; Bianciotto CG; Jabbour P; Ramasubramanian A; Lally SE; Griffin GC; Rosenwasser R; Shields JA
Arch Ophthalmol; 2011 Nov; 129(11):1399-406. PubMed ID: 21670328
[TBL] [Abstract][Full Text] [Related]
37. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
[TBL] [Abstract][Full Text] [Related]
38. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma].
Qian J; Xue K; Gao YJ; Yuan YF; Shan HD; Bi YW
Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):312-6. PubMed ID: 20654057
[TBL] [Abstract][Full Text] [Related]
39. Intravitreal topotecan for vitreous seeds in retinoblastoma: A long-term review of 91 eyes.
Sen M; Rao R; Mulay K; Reddy VAP; Honavar SG
Ophthalmology; 2024 May; ():. PubMed ID: 38703794
[TBL] [Abstract][Full Text] [Related]
40. A retrospective review of visual outcome and complications in the treatment of retinoblastoma.
O'Doherty M; Lanigan B; Breathnach F; O'Meara A; Gallie B; Chan H; O'Keefe M
Ir Med J; 2005 Jan; 98(1):17-20. PubMed ID: 15782728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]